A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren
Clinical trial NCT03796637 · COMPLETED
Trial details
- NCT number
- NCT03796637
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2019-06-03
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.